Casi Pharmaceuticals Inc Expected To Post A Loss Of 63 Cents A Share: Earnings Preview

CASI Pharmaceuticals

16/08/2024 14:45

* CASI Pharmaceuticals Inc  CASI.OQ   CASI.O  is expected
to show
a fall in quarterly revenue when it reports  results on August
20 for the period ending June 30 2024
    * The Beijing-based  company is expected to report a
54.9% decrease in revenue to $4.431 million from $9.82 million a
year ago, according to the estimate from one analyst, based on
LSEG data.
    * ​LSEG's mean analyst estimate for CASI Pharmaceuticals Inc
is
for a loss of 63 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for CASI
Pharmaceuticals Inc is $6.00​, below​ its last closing price
of $6.56. ​​​

This summary was machine generated August 16 at 13:45 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)